Introduction
Remodeling of the extracellular matrix (ECM) during tissue development, wound healing and tumor invasion requires the functions of extracellular proteinases that remodel ECM proteins at the leading edges of invading or migrating cells (Werb, 1997) . Matrix metalloproteinases (MMPs) are secreted into the extracellular space as zymogens that are functionally activated through self-proteolytic cleavage or through proteolysis by other MMPs or proteinases (Werb, 1997) . Activated MMPs play important roles in promoting tumor growth, progression and invasion. They can be expressed either directly by tumor cells (Canete-Soler et al., 1994; Jiang and Muschel, 2002; Pyke et al., 1992) or by other cells present in the tumor microenvironment, such as stromal cells or infiltrating inflammatory cells (Coussens et al., 2000; Werb, 1997) .
MMP-9/gelatinase B belongs to the gelatinase subgroup of the MMP family and its expression and activity has been correlated with different stages of carcinoma progression. For example, MMP-9 has been shown to induce the angiogenic switch in a mouse model of pancreatic carcinogenesis (Bergers et al., 2000) . Other studies have implicated MMP-9 gene activation in promoting tumor invasion and metastasis (Bernhard et al., 1994; Kupferman et al., 2000) . Many potential substrates have been identified for MMP-9 that could contribute to its tumor-promoting functions, including numerous ECM proteins, other MMPs and proteinase inhibitors (Liu et al., 2000; Werb, 1997) .
MMP-9 expression can be regulated at several levels. Although most published studies have focused on transcriptional control of MMP-9 (reviewed by Westermarck and Kahari, 1999) , there is increasing evidence that its expression can also be regulated at the steps of mRNA stability, translation and protein secretion (Akool et al., 2003; Eberhardt et al., 2002; Jiang and Muschel, 2002; Morini et al., 2000; Sehgal and Thompson, 1999; Thant et al., 2000) . The ability to modulate MMP-9 expression at multiple steps through distinct signaling pathways may be particularly important during malignant conversion and metastasis, when tumor cells need to induce or maintain MMP-9 levels in response to changing environmental cues. A number of distinct extracellular stimuli, including growth factors, cytokines and extracellular calcium, have been shown to regulate MMP-9 expression in normal or malignant keratinocytes via the Matrix metalloproteinases facilitate cell migration and tumor invasion through their ability to proteolyse the extracellular matrix. The laminin-binding integrin α3β1 is expressed at high levels in squamous cell carcinomas and in normal keratinocytes during cutaneous wound healing. We showed previously that α3β1 is required for MMP-9/gelatinase B secretion in immortalized mouse keratinocytes (MK cells) and that this regulation was acquired as part of the immortalized phenotype, suggesting a possible role for α3β1 during malignant conversion. In the current study, we identify a novel mechanism whereby α3β1 regulates the induction of MMP-9 expression that occurs in response to activation of a MAPK kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway. Inhibition of MEK/ERK signaling in wild-type MK cells with a pharmacological inhibitor, U0126, showed that ERK activation was necessary for high levels of endogenous MMP-9 gene expression and activity of a transfected MMP-9 promoter. Furthermore, activation of MEK/ERK signaling in these cells with an oncogenic mutant of Ras, RasV12, increased both endogenous MMP-9 gene expression and MMP-9 promoter activity. Experiments with α3β1-deficient MK cells revealed that α3β1 was required for both baseline levels and RasV12-induced levels of MMP-9 mRNA expression. However, α3β1 was not required for RasV12-mediated activation of ERK or for ERK-dependent MMP-9 promoter activity. Direct comparison of mRNA turnover in the wild type and α3-null MK cells identified a requirement for α3β1 in stabilization of MMP-9 mRNA transcripts. These results identify a novel function for integrins in promoting mRNA stability as a mechanism to potentiate MAPK-mediated gene expression. They also suggest a role for α3β1 in maintaining high levels of MMP-9 mRNA expression in response to oncogenic activation of MEK/ERK signaling pathways.
mitogen-activated protein kinases (MAPKs) p38 and/or extracellular signal-regulated kinase (ERK) (Johansson et al., 2000; McCawley et al., 1998; Mukhopadhyay et al., 2004; Westermarck and Kahari, 1999; Zeigler et al., 1999) . In addition, several studies have demonstrated the importance of cell adhesion in regulating the expression of MMP-9 or other MMPs in immortalized epithelial cells or carcinoma-derived cells (DiPersio et al., 2000; Lochter et al., 1999; Morini et al., 2000; Thomas et al., 2001 ).
Integrins are the major receptors for cell adhesion to the ECM and many integrins initiate 'outside-in' signal transduction events that modulate cell functions such as gene expression, cell migration and invasion (Hynes, 2002) . α3β1 integrin is expressed at high levels on epithelial cells where it is a major receptor for laminin-5 (LN-5) and other basement membrane laminins (Kreidberg, 2000) . Knockout studies in mice have revealed important roles for α3β1 in maintaining basement membrane integrity during embryonic development of the epidermis and other tissues (DiPersio et al., 1997; Kreidberg et al., 1996) . α3β1 is also expressed at high levels in most primary and metastatic tumors (Bartolazzi et al., 1994; Natali et al., 1993; Patriarca et al., 1998) and several recent studies in immortalized epithelial cells or carcinoma-derived cell lines suggest that this integrin has important roles in regulating functions that promote malignant tumor growth and progression, including cell survival, migration, invasion and metastasis (Morini et al., 2000; Choma et al., 2004; Wang et al., 2004; Manohar et al., 2004) . Some of these α3β1-mediated cell functions may involve MMP-9, as α3β1 regulates MMP-9 secretion in some immortalized and malignantly transformed epithelial cells (Morini et al., 2000; DiPersio et al., 2000) . We showed previously that α3β1-dependent secretion of MMP-9 was acquired as part of the immortalized phenotype in keratinocytes (DiPersio et al., 2000) , consistent with a role during malignant conversion of squamous cell carcinoma (SCC). Many invasive carcinoma cells also express high levels of LN-5 (Pyke et al., 1995) and MMP-9 (Juarez et al., 1993; Morini et al., 2000; Pyke et al., 1992; Westermarck and Kahari, 1999) , reinforcing a possible link between α3β1-mediated adhesion and MMP-9 induction during tumor progression and invasion.
Despite the established importance of integrins in regulating MMP gene expression in immortalized or transformed epithelial cells, the mechanisms of this regulation are still unclear. In the current study, we determined the mechanism whereby α3β1 integrin regulates the induction of MMP-9 gene expression in immortalized keratinocytes cultured on LN-5. We showed that ERK activation was necessary for high levels of MMP-9 expression and that α3β1 was necessary for ERKmediated induction of MMP-9 in response to oncogenic RasV12. Importantly, although α3β1 was required for high levels of MMP-9 mRNA, it was not required for RasV12-mediated activation of ERK, or for ERK-mediated activation of a transfected MMP-9 promoter construct. However, α3β1 was required post-transcriptionally to maintain high levels of MMP-9 mRNA, as mRNA decay experiments indicated that MMP-9 transcripts turn over more rapidly in α3-null cells than in α3β1-expressing cells. These results identify a novel function for α3β1 integrin in promoting mRNA stability as a mechanism to potentiate MAPK-mediated gene expression. In addition, our findings suggest an important role for α3β1 integrin in augmenting the response of some immortalized or transformed cells to growth factors and other environmental cues, or to activated oncogenes, that stimulate MMP-9 gene expression through MAPK signaling pathways.
Materials and Methods
MK cell culture and stable transfection with α3 integrin The MK +/+ cell line (MK-1.16) and MK -/-cell line (MK-5.4.6) were derived from keratinocytes isolated from wild-type mice or α3 integrin knockout mice, respectively (DiPersio et al., 2000) . MK growth medium consisted of Eagle's minimum essential medium (EMEM; BioWhittaker, Walkersville, MD) supplemented with 4% FBS (BioWhittaker) from which Ca 2+ had been chelated, 0.05 mM CaCl 2 , 0.4 µg/ml hydrocortisone (Sigma, St Louis, MO), 5 µg/ml insulin (Sigma), 10 ng/ml EGF (Invitrogen Corporation, Carlsbad, CA), 2×10 -9 M T3 (Sigma), 10 U/ml interferon γ (INFγ; Sigma), 100 U/ml penicillin and 100 µg/ml streptomycin (Invitrogen) and L-glutamine (Invitrogen). MK cell lines were maintained at 33°C, 8% CO 2 , on tissue culture plates coated with 30 µg/ml denatured rat tail collagen (Cohesion, Palo Alto, CA). For experiments, MK cells were subcultured on laminin-5-rich extracellular matrix (LN-5 ECM) prepared from the human squamous cell carcinoma line SCC-25 (Rheinwald and Beckett, 1981) , as described previously (DiPersio et al., 2000) . For experiments in Fig. 4 , untreated or LN-5 ECM coated tissue culture plates were coated with fibronectin (20 µg/ml; a gift from Livingston Van De Water, Albany Medical College), vitronectin (15 µg/ml; a gift from Paula McKeown-Longo, Albany Medical College), or both fibronectin and vitronectin (20 µg/ml and 15 µg/ml, respectively), then blocked with 10 mg/ml heat-denatured BSA in PBS. For assessment of cell spreading and F-actin, parallel cultures were grown under serum-free conditions for 24 hours on glass coverslips coated with ECM proteins as described above, fixed in 4% paraformaldehyde and stained with TRITC-conjugated phalloidin (Sigma). Images were acquired on an Olympus BX60 microscope using a cooled CCD camera (Sensicam) and the software Slidebook 3.0.
α3β1 integrin expression was restored in MK -/-cells by stable transfection with the plasmid pCMVzeo-hα3A, which contains the full-length human α3 cDNA (a generous gift from Martin Hemler, Dana-Farber Cancer Institute, Boston, MA) cloned into the XbaI site proximal to the CMV promoter in pcDNA3.1/Zeo(+) (Invitrogen). MK -/-cells were transfected using lipofectamine reagent (Invitrogen). Pools of zeocin-resistant cells were expanded and assayed for α3β1 surface expression by FACS analysis with the anti-human α3 monoclonal antibody P1B5 (Gibco/BRL, Gaithersburg, MD), as described previously (DiPersio et al., 2000) .
Western blotting MK cell lysates were prepared in cell lysis buffer (Cell Signaling Technology, Beverly, MA) and equal amounts of protein from each lysate (either 10 µg or 20 µg) was subject to reducing 10% SDS-PAGE. Proteins were then transferred to nitrocellulose membranes and assayed by western blot. Primary antibodies were used at the following concentrations: rabbit anti-phosphorylated ERK1/2 (Cell Signaling Technology), 1:1000; rabbit anti-ERK1/2 (Promega, Madison, WI), 1:5000; mouse monoclonal anti-HA-tag (Covance Inc., Princeton, NJ), 1:1000. Peroxidase (HRP)-conjugated secondary antibodies were used at the following concentrations: goat anti-rabbit IgG (Cell Signaling Technology), 1:2000; goat anti-rabbit IgG (Pierce, Rockford, IL), 1:15,000; goat anti-mouse IgG (Pierce),α3β1 integrin regulates MMP-9 mRNA stability previously (DiPersio et al., 2000) . Briefly, MK cells were plated onto 12-well tissue culture plates coated with LN-5 ECM at 1.4×10 5 cells per well and allowed to attach overnight in MK growth medium. Cultures were then rinsed and maintained in serum-free medium for an additional 36 or 48 hours, as indicated in figure legends, and culture media were collected for zymography. In some experiments, cells were treated with the MEK inhibitor U0126 (10 µm), as described in the figure legends. All zymography experiments were performed in the absence of INFγ, since INFγ has been reported to inhibit MMP-9 expression (Hujanen et al., 1994) . The same zymography results were obtained whether cells were grown in serum-free medium containing or lacking additional hormonal supplements that are normally present in MK growth medium (see above). MMPs were concentrated from culture media by binding overnight at 4°C to gelatin-agarose beads (Sigma). Agarose beads were recovered by centrifugation, and bound MMPs were eluted in zymography sample buffer (2.25% SDS, 9% glycerol, 45 mM Tris-HCl, pH 6.8, Bromophenol Blue) and resolved by non-reducing SDS-PAGE on 10% polyacrylamide gels impregnated with 1 mg/ml gelatin (Sigma). Gels were processed for zymography as described previously (DiPersio et al., 2000) .
Analysis of MMP-9 mRNA
For northern blots, MK cells were cultured on LN-5 ECM for 4 days in serum-containing growth medium, and total cellular RNA was isolated using the Purescript RNA isolation kit (Gentra Systems, Minneapolis, MN). 10 µg total RNA was denatured at 55°C for 15 minutes in 1× MOPS, 6.5% formaldehyde and 50% formamide prior to electrophoresis on agarose-formaldehyde gels (1.2% agarose, 1.1% formaldehyde, 1× MOPS). RNA was then transferred to Nytran membranes in 10× SSC (3 M NaCl, 0.3 M sodium citrate, pH 7.0), UV cross-linked and incubated for 3 hours at 42°C in prehybridization buffer (50% formamide, 5× Denhardt's solution, 1% SDS, 150 µg/ml salmon sperm DNA, 5× SSC). Blots were then incubated overnight at 42°C in hybridization buffer (pre-hybridization buffer with 2.5× Denhardt's solution and 10% dextran sulfate) containing a 32 P-labeled cDNA probe against mouse MMP-9 (a generous gift from Karl Tryggvason, University of Oulu, Finland), washed and exposed to autoradiographic film. Blots were stripped and reprobed with a cDNA probe against A50 ribosomal protein as a control, as its expression does not change in response to cell adhesion (Samarakoon and Higgins, 2002) .
For RT-PCR, total RNA was isolated as described above and reverse transcribed to produce cDNA template using the first-strand cDNA synthesis kit (Promega). PCR reactions were carried out in 12.5 µl PCR REDTaq ReadyMix (Sigma) with 5 µl cDNA and 0.4 µM of each primer. PCR conditions were 94°C for 60 seconds, 58°C for 90 seconds and 72°C for 90 seconds. Samples were subjected to 28 cycles for MMP-9 and 15 cycles for β-actin, with the last cycle for each at 72°C for 7 minutes. PCR primers for MMP-9 were as described (Bouloumie et al., 2001 ) and generate a 371 bp product: forward primer, 5′-TGTACCGCTATGGTTACAC-3′; reverse primer, 5′-CCGCGACACCAAACTGGAT-3′. An alternative set of MMP-9 primers was used for certain experiments, as described (Kim et al., 2000) and generates a 754 bp product: forward primer, 5′-AGTT-TGGTGTCGCGGAGCAC-3′; reverse primer, 5′-TACATGAGCG-CTTCCGGCAC-3′. PCR conditions for these primers were similar to those described above, except that the annealing temperature was increased to 64°C for 60 seconds. PCR primers for β-actin were as described and generate a 450 bp product: forward primer, 5′-AGGGAAATCGTGCGTGACAT-3′; reverse primer, 5′-CATCTGCTGGAAGGTGGACA-3′. PCR products were run on a 1.8% agarose gel, stained with ethidium bromide and visualized using a Bio-Rad Gel-Doc 2000. Signals were quantified using Quantity One software (Bio-Rad, Hercules, CA). The number of PCR cycles was optimized so that signals were within the linear range of detection for both MMP-9 and β-actin.
For assaying mRNA turnover, cells cultured on LN-5 ECM in serum-free MK growth medium were pre-treated with 10 µg/ml cycloheximide for 16 hours to promote accumulation of MMP-9 mRNA, as described . Cycloheximide was then removed and 4 hours later cells were switched to serum-free MK growth medium containing 10 µg/ml actinomycin D to inhibit transcription. Control experiments demonstrated that this concentration of actinomycin D effectively inhibited transcription from the MMP-9 promoter in MK cells (data not shown). The initial time point was collected 30 minutes after actinomycin D treatment. Subsequent time points were collected as indicated in the figure legend and assayed for MMP-9 mRNA and β-actin mRNA levels by RT-PCR.
Adenoviral infection of MK cells
MK cells were sub-cultured on LN-5 ECM in growth medium overnight and then infected for 24 hours with adenovirus expressing either HA-tagged RasV12 or β-galactosidase as a control. RasV12 and β-galactosidase were cloned into pAdTrack, as described (Meadows et al., 2001) . Multiplicity of infection (MOI) for each experiment is provided in the figure legends. In some experiments, cells were pretreated for 3 hours with 10 µM U0126 (Calbiochem, San Diego, CA), or with DMSO as a control, then cultured in serum-free medium for an additional 24-48 hours in the presence or absence of U0126, as indicated; for zymography experiments, U0126 was replenished in the medium every 12 hours. Culture media were assayed by zymography and cell lysates were assayed by western blotting, as described above.
Analysis of the transfected MMP-9 promoter
An MMP-9 promoter/firefly luciferase reporter plasmid was a generous gift from Y. Sasaguri (University of Occupational and Environmental Health, Kitakyushu, Japan) and contained a 1868 bp DNA fragment of the MMP-9 promoter region (-1879 to -12 from the transcription start site) cloned upstream of the luciferase gene in the pGL3 vector (Promega), as described (Shimajiri et al., 1999) . Uninfected MK cells, or MK cells infected with RasV12 adenovirus (see above), were co-transfected with the MMP-9 promoter/luciferase reporter plasmid and a TK promoter/Renilla luciferase control plasmid (pRLTK, Promega) at a 50:1 ratio using lipofectamine. Following a 5 hour transfection, cells were cultured in MK growth medium without serum (unless otherwise indicated), in the presence or absence of 10 µM U0126 for an additional 24 hours. Cell lysates were then collected and assayed for luciferase expression using the Dual-Luciferase Reporter Assay Kit (Promega). Luciferase expression was measured in a TD-20/20 luminometer (Turner Designs) and expression from the MMP-9 promoter/luciferase plasmid was normalized to that from the control pRLTK plasmid for each sample. Normalized luciferase signals were then plotted as described in the legend to Fig. 5 .
Results
A MEK/ERK signaling pathway is necessary for MMP-9 expression in immortalized mouse keratinocytes MMP-9 production is dependent on expression of α3β1 integrin in immortalized mouse keratinocytes (MK cells) cultured on laminin 5-rich extracellular matrix (LN-5 ECM) and this mode of regulation was acquired as part of the immortalized phenotype (DiPersio et al., 2000) . ERKs are phosphorylated and activated by MEKs, and MEK/ERK pathways have been shown to regulate MMP-9 gene expression in a number of cell types (Gum et al., 1997; McCawley et al., 1999; Zeigler et al., 1999; Genersch et al., 2000) . To determine whether MEK/ERK signaling is required for MMP-9 expression in MK cells, wild-type MK +/+ cells cultured on LN-5 ECM were treated with the MEK-specific inhibitor, U0126, and gelatin zymography was used to assess levels of MMP-9 secreted into the culture medium. Inhibition of MEK caused decreased levels of MMP-9 production by MK +/+ cells (Fig. 1) . We showed previously that expression of MMP-9 protein was absent from α3β1-deficient MK -/-cells, but was restored in these cells by transfection with the human α3 subunit (DiPersio et al., 2000) . This α3β1-mediated restoration of MMP-9 expression was also blocked with the MEK inhibitor (data not shown). To confirm that MEK-dependent ERK activation was inhibited effectively by U0126 in these experiments, lysates from the same cells were immunoblotted for the activated forms of ERK1/2 with an antibody specific for phosphorylation on residues Thr202 and Tyr204. Levels of activated ERK were reduced in U0126-treated cells (Fig. 1, pERK blot) , whereas levels of total ERK protein were unchanged (Fig. 1, ERK blot) . These results demonstrate that signaling through MEK/ERK is necessary for MMP-9 expression in MK cells.
Activation of MEK/ERK signaling by oncogenic RasV12 induces MMP-9 protein levels in an α3β1-dependent manner As activation of ERK is necessary for MMP-9 expression in the MK +/+ cells, we next tested whether ERK activation is sufficient to induce MMP-9 expression in the α3β1-deficient MK -/-cells. Ras is a small GTPase that activates the MEK/ERK signaling pathway. Oncogenic mutations in the cras Ha gene occur frequently in skin tumors (Yuspa, 1994) and Ras activation has been shown to induce expression of MMP-9 (Genersch et al., 2000; Gum et al., 1996) . We expressed a constitutively activated mutant of Ras, RasV12, in the MK cells and determined the effects on ERK activation and MMP-9 expression. MK +/+ and MK -/-cells were each infected with an adenovirus expressing either HA-tagged RasV12 or β-galactosidase as a control. For both MK +/+ cells and MK -/-cells, we did not observe any obvious differences in morphology between RasV12-infected and control-infected cells (data not shown). Gelatin zymography showed that expression of RasV12 in MK +/+ cells induced levels of secreted MMP-9 considerably above basal levels detected in controlinfected cells (Fig. 2, mMMP-9, compare lanes 1 and 3) . The induction of MMP-9 by RasV12 was MEK/ERK dependent as treatment with U0126 abrogated this response (Fig. 2, mMMP-9, compare lanes 3 and 4) . Immunoblots of lysates from the corresponding cell layers confirmed the presence of HA-tagged RasV12 in infected cells (Fig. 2, RasV12, lanes 3 and 4) . Immunoblotting for phosphorylated ERK confirmed that RasV12 caused an increase in ERK activation and that this activation was MEK-dependent (Fig. 2, pERK) .
In stark contrast with the results in MK +/+ cells, RasV12 was unable to induce MMP-9 levels in MK -/-cells (Fig. 2 , mMMP-9, compare lanes 5 and 7) suggesting that α3β1 is required for RasV12-mediated induction of MMP-9. The inability of RasV12 to induce MMP-9 was not due to a defect in ERK activation, since ERK was phosphorylated robustly in RasV12-infected MK -/-cells (Fig. 2 , pERK, lane 7). Thus, oncogenic RasV12 was able to activate ERK in both MK -/-cells and MK +/+ cells, but it did not induce MMP-9 secretion in the MK -/-cells, demonstrating that α3β1 is required for MMP-9 expression at a point downstream of ERK activation.
α3β1 is required for MMP-9 mRNA accumulation Regulation of MMP-9 expression has been reported to occur at the levels of gene transcription, mRNA stability and protein Journal of Cell Science 118 (6) Fig. 1 . MEK/ERK signaling is required for MMP-9 expression in MK cells. Wild-type MK +/+ cells were grown on laminin-5-rich extracellular matrix (LN-5 ECM) in serum-free medium for 36 hours in the presence or absence of the MEK inhibitor U0126 (10 µM), as indicated. MMP-9 levels in the culture medium were assayed by gelatin zymography (top panel). Position of the 105 kDa murine pro-MMP-9 (mMMP-9) is indicated on the left. S lane, positions of human MMP-9 (hMMP-9) and MMP-2 (hMMP-2) purified standards are indicated. ERK activation was assayed by immunoblot of the corresponding cell lysates for phospho-ERK (pERK panel). Blots were stripped and reprobed for total ERK (ERK panel). -/-cells (MK-/-) grown on LN-5 ECM were infected with adenovirus expressing either HA-tagged RasV12 (RasV12) or β-galactosidase (control); MOI=70. Cells were then grown in serum-free medium for an additional 36 hours in the presence or absence of 10 µM U0126, as indicated. Levels of secreted MMP-9 in the culture medium were assayed by gelatin zymography (top panels); murine MMP-9 and human MMP-9 standard are indicated. To confirm RasV12 expression, equal protein from corresponding cell lysates was immunoblotted with anti-HA tag (RasV12 panel). Parallel blots with anti-phospho-ERK confirmed ERK activation in RasV12-infected cells and inhibition of ERK activation by treatment with U0126 (pERK panel). α3β1 integrin regulates MMP-9 mRNA stability production/secretion (Akool et al., 2003; Eberhardt et al., 2002; Jiang and Muschel, 2002; Morini et al., 2000; Sehgal and Thompson, 1999; Thant et al., 2000; Westermarck and Kahari, 1999) . In order to determine whether α3β1 regulates MMP-9 mRNA levels, we performed northern blot analysis on total RNA isolated from MK cells cultured on LN-5 ECM in the presence of serum for 4 days, conditions which support similarly high survival of both MK +/+ cells and MK -/-cells (Manohar et al., 2004) . Two distinct MMP-9 mRNA transcripts were detected in MK +/+ cells, a major transcript of ~3.5 kb and a minor transcript of ~2.7 kb (Fig. 3A , +/+ lane), as described for other cell types (Graubert et al., 1993; Tanaka et al., 1993) . However, MMP-9 transcripts were undetectable in MK -/-cells (Fig. 3A , -/-lane) suggesting that α3β1 is required for MMP-9 mRNA expression. Indeed, restoration of α3β1 integrin expression in MK -/-cells through stable transfection with the human α3 subunit (see Fig. 3C ) restored MMP-9 mRNA expression (Fig. 3A , -/-, α3 lane), whereas transfection with a control vector did not (Fig. 3A , -/-, V lane). Using the more sensitive method of RT-PCR, we confirmed that MMP-9 mRNA was detected in MK +/+ cells and in α3-transfected MK -/-cells, but was barely detectable in α3β1-deficient MK -/-cells ( Fig. 3B) . We showed previously that α3-null MK -/-cells cultured on LN-5 ECM fail to spread properly and display reduced actin stress fiber formation (DiPersio et al., 2000; Choma et al., 2004) , suggesting that reduced MMP-9 expression in these cells could be caused by a general spreading defect. Indeed, previous studies have shown that MMP expression can be regulated by changes in cell spreading and actin cytoskeletal organization (Kheradmand et al., 1998; Yan et al., 2000) . To test whether restoring cell spreading to MK -/-cells can induce MMP-9 expression, MK -/-cells were plated either on a mixture of LN-5 ECM plus fibronectin or on purified fibronectin. MK -/-cells were able to spread on both fibronectin alone (Fig. 4B, c  and d ) and LN-5 ECM plus fibronectin (data not shown). However, neither of these substrates induced MMP-9 expression above the low basal levels seen on LN-5 ECM alone (Fig. 4A) . By contrast, MK +/+ cells showed high levels of MMP-9 mRNA expression on either substrate (Fig. 4A) ; MMP-9 expression on fibronectin alone was probably due to deposition of endogenous LN-5 (DiPersio et al., 2000) .
Although MK -/-cells were able to spread on fibronectin, the degree of spreading was detectably lower in MK -/-cells ( (Fig. 4d, arrow) and/or fewer stress fibers. The expression of other endogenous integrins is similar in the MK +/+ cells and MK -/-cells (DiPersio et al., 2000) , suggesting that the ability of MK +/+ cells to spread better on fibronectin is most likely due to their ability to adhere to endogenously deposited LN-5 through α3β1 (Frank et al., 2004; DiPersio et al., 2000) . In an attempt to enhance MK -/-cell spreading, we also tested a mixed substrate of fibronectin plus vitronectin. Under these conditions, MK -/-cells showed markedly improved spreading and stress fiber formation that approached that seen in MK +/+ cells (Fig. 4B , e-h), although subtle differences in the number of spindle-shaped cells remained (Fig. 4B, h, arrow) . Despite improved spreading, MK -/-cells still showed considerably lower MMP-9 mRNA levels than did MK +/+ cells on fibronectin plus vitronectin (Fig. 4A, F+V) . α3β1-dependent MMP-9 expression was also seen in MK cells cultured on vitronectin alone (Fig. 4A, V) . Taken together, our results indicate that α3β1 is required for MMP-9 mRNA expression and that engagement of other endogenous integrins/ECM receptors and subsequent spreading is not sufficient to restore MMP-9 expression in MK -/-cells. Nevertheless, we cannot rule out a requirement for cell spreading, or a role for subtle aspects of cell spreading or cytoskeletal organization, in the α3β1-dependent regulation of MMP-9.
α3β1 is not required for MEK/ERK-dependent MMP-9 promoter activity MEK/ERK signaling has been shown to regulate transcriptional activation of the MMP-9 promoter (Westermarck and Kahari, 1999) . Given that α3β1 was required for MEK/ERK-mediated induction of MMP-9 expression, we next tested whether α3β1 is also required for MEK/ERK-mediated activation of the MMP-9 promoter. For these experiments, we used an MMP-9 promoter-driven luciferase assay that was shown previously to provide a sensitive measure of transcriptional responsiveness (Shimajiri et al., 1999) . MK cells cultured on LN-5 ECM were transfected with a reporter plasmid containing the firefly luciferase gene under transcriptional control of a ~1.9 kb MMP-9 promoter fragment that includes the major regulatory elements for responsiveness to growth factors and cytokines (Shimajiri et al., 1999; Westermarck and Kahari, 1999) . Interestingly, MMP-9 promoter activity was reduced only slightly in MK -/-cells compared with MK +/+ cells and restoring α3β1 expression in the former cells did not increase promoter activity (Fig. 5A) , indicating that activity of the transfected promoter was independent of α3β1. Treatment with U0126 reduced MMP-9 promoter activity below basal levels in MK +/+ cells, MK -/-cells and α3-transfected MK -/-cells (Fig. 5B) , indicating that MEK/ERK signaling is necessary for baseline MMP-9 promoter function regardless of α3β1 expression. We have consistently observed reduced levels of phosphorylated ERK in MK -/-cells compared with MK +/+ cells or α3-transfected MK -/-cells, indicating that α3β1 is required for full ERK activation in these cells (Manohar et al., 2004) . Nevertheless, the results presented here show that basal ERK activity in MK -/-cells is both necessary (Fig. 5B) and sufficient ( Fig. 5A ) for MMP-9 promoter activity.
To determine whether oncogenic Ras can induce MEK/ERK-dependent activation of the MMP-9 promoter, MK cells that had been infected with the RasV12 adenovirus were transfected with the MMP-9 promoter/luciferase reporter plasmid and cultured in the presence or absence of U0126. RasV12 induced the MMP-9 promoter in MK +/+ cells more than threefold over basal levels seen in uninfected cells (Fig.   5B , MK +/+ ) consistent with the induction of endogenous MMP-9 that was detected in these cells by zymography (Fig. 2) . RasV12 also induced the MMP-9 promoter in α3-transfected MK -/-cells (Fig. 5B,  α3) . MMP-9 promoter activity in RasV12-infected cells was reduced below basal levels upon treatment with U0126 (Fig.  5B) , showing that RasV12-mediated induction of the MMP-9 promoter is MEKdependent. These results suggest that RasV12-mediated induction of MMP-9 secretion in MK +/+ cells is due, at least partly, to activation of a MEK/ERK signaling pathway that induces the MMP-9 promoter.
Importantly, even though RasV12 also induced the MMP-9 promoter in α3β1-deficient MK -/-cells (Fig. 5B , MK -/-), there was not a concomitant induction of endogenous MMP-9 secretion by RasV12 in these cells (Fig. 2) . These results were confirmed in a separate set of experiments in which transfected MK -/-cells were assayed simultaneously for luciferase expression and for endogenous MMP-9 protein expression (data not shown). Thus, α3β1 was not required for induction of the transfected MMP-9 promoter by Ras/ MEK/ERK signaling, but it was required for endogenous MMP-9 expression in the same cells. As promoter-driven luciferase assays are an indirect measure of a gene's transcriptional activity, our results do not rule out a role for α3β1 in transcriptional regulation of the endogenous MMP-9 gene. Nevertheless, they prompted us to explore the possibility that α3β1 has a posttranscriptional role in MMP-9 mRNA accumulation (see below).
α3β1 is required for induction of endogenous MMP-9 mRNA by oncogenic RasV12 As RasV12 was able to induce the MMP-9 promoter independently of α3β1 (Fig. 5B) , but accumulation of endogenous MMP-9 mRNA required α3β1 (Fig. 3) , we next determined whether the ability of RasV12 to induce steadystate levels of endogenous MMP-9 mRNA was dependent on α3β1. MK +/+ cells and MK -/-cells were cultured on LN-5 ECM and infected with adenovirus expressing either HAtagged RasV12 or β-galactosidase as a control. MMP-9 and β-actin mRNA levels were then assayed by RT-PCR (Fig. 6A) and signals for MMP-9 were normalized to those for β-actin (Fig. 6B) . Although RasV12 had a slight inductive effect on MMP-9 mRNA levels in MK -/-cells, substantial induction by RasV12 was dependent on expression of α3β1 (Fig. 6B) . Taken together, results from Figs 5 and 6 suggest that α3β1 may potentiate RasV12-mediated induction of MMP-9 mRNA through a mechanism that is downstream from ERK-dependent promoter activation. One possibility is that α3β1 promotes Journal of Cell Science 118 (6) α3β1 promotes MMP-9 mRNA stability To directly compare MMP-9 mRNA stability between α3-null and α3-expressing MK cells, we utilized an established approach to inhibit new gene transcription and measure MMP-9 mRNA decay over time (Sehgal and Thompson, 1999) . Owing to the very low basal level of MMP-9 mRNA in the MK -/-cells, it was necessary to first induce MMP-9 mRNA to detectable levels in these cells so that we could monitor the rate of mRNA turnover. Previous studies of mRNA stability have shown that treatment with the translation inhibitor cycloheximide leads to accumulation of unstable mRNAs in some cells, possibly by inhibiting new synthesis of labile destabilization factors that promote mRNA turnover (reviewed in Guhaniyogi and Brewer, 2001) . Indeed, in preliminary experiments we observed that MMP-9 mRNA expression in α3-null MK -/-cells was induced ~tenfold to easily detectable levels by treatment with 10 µg/ml cycloheximide (data not shown). Therefore, cells were pre-treated with cycloheximide to induce accumulation of MMP-9 mRNA in the MK -/-cells. Cells were then cultured in the presence of the transcriptional inhibitor actinomycin D to prevent new mRNA synthesis, allowing us to monitor MMP-9 mRNA decay over a time course as described previously (Sehgal and Thompson, 1999) . RT-PCR was used to assess mRNA levels for MMP-9, or for β-actin as a control. MMP-9 mRNA levels remained high for up to 24 hours in MK +/+ cells (Fig. 7A, diamonds) . By contrast, by 24 hours MMP-9 mRNA levels dropped to 37% of original levels in MK -/-cells cultured under identical conditions (Fig.  7A, squares) , indicating dramatically decreased mRNA stability in these cells. Restoring expression of α3β1 in MK -/-cells resulted in increased MMP-9 mRNA levels at each time point, compared with untransfected MK -/-cells (Fig. 7A , open circles). In contrast with MMP-9 mRNA, β-actin mRNA levels were comparable between α3β1-expressing MK cells and α3-null MK cells at each time point (Fig. 7B) , demonstrating that α3β1-mediated effects on transcript stability were specific to MMP-9 mRNA. These results identify a novel role for α3β1 in promoting MMP-9 mRNA stability and they provide a mechanism whereby the integrin can potentiate the induction of MMP-9 expression in response to oncogenic Ras or other activators of MEK/ERK-mediated gene transcription.
Discussion
Integrins have been shown to play important roles in regulating MMP-9 expression in immortalized epithelial cells and cell lines derived from SCC and breast carcinomas (DiPersio et al., 2000; Morini et al., 2000; Thomas et al., 2001) . However, the mechanisms whereby integrins regulate MMP-9 gene expression have been unclear. In the current study, we demonstrated that α3β1 integrin is required for accumulation of MMP-9 mRNA following MEK/ERK-mediated induction of the MMP-9 gene in immortalized keratinocytes. We propose a model in which α3β1 potentiates MEK/ERK-induced MMP-9 synthesis by regulating mRNA stability downstream of ERKmediated promoter activation (Fig. 8) . Through this mechanism, α3β1 potentiates induction of MMP-9 mRNA and +/+ and MK -/-cells were infected with adenovirus expressing either β-galactosidase as a control (-lanes) or RasV12 (+ lanes), then cultured on LN-5 ECM for 48 hours in serum-free medium. Total RNA was isolated and RT-PCR was performed to compare MMP-9 and β-actin mRNA levels. (B) Signals for MMP-9 mRNA and β-actin mRNA were quantified; graphs depict relative MMP-9 mRNA levels for each sample, after normalization to β-actin mRNA. Data are presented as the mean±s.e.m. for three separate experiments; *P<0.05, twoway ANOVA with Newman Keuls post-hoc test. protein by activated Ras. Thus, our data identify a novel mechanism whereby integrins can regulate MMP gene induction following the activation of MAPK pathways that stimulate transcription.
The acquisition of α3β1-dependent MMP-9 expression by immortalized keratinocytes may reflect an important role for α3β1 during malignant progression of SCCs or other tumors, as discussed below. Our findings may also be relevant to other tissue remodeling events in which α3β1 has been implicated, such as embryonic tissue development or wound healing (Kreidberg, 2000) . It seems likely that α3β1-mediated regulation of MMP-9 expression is controlled by α3β1 binding to LN-5, as it is well established that α3β1 is a strong receptor for keratinocyte adhesion to LN-5 (Kreidberg, 2000) . Alternatively, or in addition, MMP-9 expression may be controlled by functions of α3β1 at sites of cell-cell adhesion, as α3β1 was recently shown to be a functional component of E-cadherin-mediated adherens junctions in kidney collecting duct epithelial cells (Chattopadhyay et al., 2003) . Indeed, we recently demonstrated that monolayer cultures of α3β1-deficient MK -/-cells show reduced cell-cell interactions (Choma et al., 2004) and we have determined that α3β1 is physically and functionally associated with E-cadherin at MK cell-cell junctions (N. Myneni and M.D., unpublished) . Future experiments will address the relative importance of α3β1 functions at cell-ECM adhesions and cell-cell adhesions in the regulation of MMP-9 expression.
Although most previous studies of MMP-9 gene expression have focused on transcriptional control, it has become increasingly evident that post-transcriptional mechanisms play critical roles in the regulation of MMP-9 mRNA levels in response to growth factors and cytokines (Akool et al., 2003; Sehgal and Thompson, 1999 ). In the current study we have identified mRNA stabilization as a primary mechanism of α3β1-mediated MMP-9 induction in immortalized keratinocytes. Although regulation of mRNA stability is clearly an important post-transcriptional mechanism for the control of gene expression (Sachs, 1993) , there have been few published studies regarding the roles of integrins and ECM in the modulation of mRNA stability (Feng et al., 1999; Retta et al., 2001; Xu and Clark, 1996) and this mechanism of integrinmediated gene regulation remains largely unexplored. Regulation of mRNA half-life occurs primarily through conserved U-rich or AU-rich elements, collectively termed AREs, that are usually present in multiple, non-tandem copies within the 3′-untranslated region (3′-UTR) of mRNAs with short or variable half-lives (Brennan and Steitz, 2001 MMP-9 gene transcription can be induced by Ras/MEK/ERK signaling in response to growth factors, cytokines, or oncogenic Ras. Our data reveal a novel mechanism wherein α3β1 is required for stabilization of MMP-9 mRNA, leading to the accumulation of MMP-9 transcripts and subsequent production of MMP-9 protein in response to ERK-mediated transcriptional induction. In the absence of α3β1, transcriptional induction by Ras/MEK/ERK does not lead to substantial accumulation of MMP-9 transcript and increased MMP-9 protein owing to the destabilization and rapid decay of MMP-9 mRNA. The α3 and β1 integrin subunits are indicated. α3β1 integrin regulates MMP-9 mRNA stability interact with specific RNA-binding proteins (RBPs) that control the rate of mRNA decay. Two of the most extensively studied RBPs are HuR, which promotes mRNA stability (Brennan and Steitz, 2001 ) and AUF1/hnRNP D, several isoforms of which promote mRNA decay (Loflin et al., 1999) . The 3′-UTR of the mouse and rat MMP-9 transcripts each contain several ARE consensus sequences, some of which have been shown to bind HuR and regulate MMP-9 mRNA stability (Graubert et al., 1993; Tanaka et al., 1993; Akool et al., 2003) . Future studies should determine whether α3β1 integrin promotes MMP-9 mRNA stability by regulating the functions of specific RBPs that bind to these AREs.
Although a number of specific signal transduction pathways have been implicated in the regulation of mRNA stability (Brennan and Steitz, 2001) , several studies have reported a particularly prominent role for MAPK p38 signaling pathways in ARE-mediated mRNA stability (Montero and Nagamine, 1999; Dean et al., 1999; Reunanen et al., 2002; Winzen et al., 1999; Tran et al., 2003) . Although we have not yet identified the signaling pathways whereby α3β1 controls MMP-9 mRNA stability, we recently showed that several signaling proteins are activated by α3β1 in MK cells, including focal adhesion kinase (FAK) and the Rho family GTPase Rac1 (Choma et al., 2004; Manohar et al., 2004) . Rac1 is a particularly good candidate for mediating MMP-9 mRNA stability, as a Rac1/MKK3/p38 pathway has been shown to promote stability of the uPA mRNA in invasive breast epithelial cells . It remains to be determined whether α3β1-mediated activation of Rac1 and/or p38 regulates ARE-mediated stability of MMP-9 mRNA.
Previous studies have demonstrated cooperativity between integrins and growth factor receptors in the regulation of MAPK signaling pathways (Giancotti and Ruoslahti, 1999) . For example, growth factor-dependent induction of ERK signaling in NIH 3T3 cells is strongly dependent on integrinmediated cell adhesion (Aplin and Juliano, 1999; Renshaw et al., 1997) . In the latter studies, activation of MEK/ERK signaling was identified as an adhesion-dependent event. Our model in Fig. 8 suggests a distinct, novel mechanism whereby integrins can cooperate with growth factors or other stimuli to induce MEK/ERK-dependent gene expression. Specifically, our results in MK cells using RasV12 as an activator of MEK/ERK showed that α3β1 was not required for Rasmediated ERK activation, but that it was required for MEK/ERK-mediated induction of MMP-9 expression at a point downstream from ERK activation (i.e. mRNA stabilization). Thus, α3β1 may regulate the ability of some cells to synthesize and secrete MMP-9 in response to growth factors or cytokines that stimulate MMP-9 gene transcription through MEK/ERK pathways. In addition, our results suggest that α3β1 expressed in malignant tumors may potentiate MMP-9 induction in response to MAPK pathways that are activated constitutively by oncogenic Ras or other oncogenes. Indeed, activating mutations in the c-ras
Ha gene are among the most common initiating mutations in epidermal tumors (Yuspa, 1994) .
Carcinogenesis is generally accompanied by cellular changes that facilitate tumor growth and cell invasion, including altered ECM synthesis, altered integrin function and increased MMP expression (Johnsen et al., 1998; Werb, 1997; Westermarck and Kahari, 1999) . Tumor cells also undergo changes in their capacity to respond to extracellular signals generated from growth factors or ECM, and they are likely to acquire certain signaling pathways to induce or maintain MMP expression. As discussed above, the ability of α3β1 integrin to potentiate MEK/ERK-mediated induction of MMP-9 through mRNA stabilization may reflect an important role for this integrin in regulating the ability of some tumor cells to respond to environmental cues or oncogenes that stimulate gene transcription through MEK/ERK signaling pathways. This ability of α3β1 to induce MMP-9 expression is acquired as part of the immortalized keratinocyte phenotype (DiPersio et al., 2000) . Similarly, the ability of TGFβ to induce MMP-9 expression in prostate cancer cells is acquired during cellular transformation (Sehgal et al., 1996; Sehgal and Thompson, 1999) . In addition, changes in calcium-mediated regulation of MMP-9 expression occur during malignant transformation of oral keratinocytes (Mukhopadhyay et al., 2004) . Thus, it is clear that certain signaling pathways that regulate MMP-9 expression are activated or altered during cellular immortalization or malignant progression. Many invasive tumors show increased expression levels of α3β1 (Bartolazzi et al., 1994; Natali et al., 1993; Patriarca et al., 1998) and its ECM ligand laminin-5 (Pyke et al., 1995) and recent studies in immortalized keratinocytes and tumor-derived cell lines have demonstrated important roles for α3β1 in several cell functions that contribute to tumor growth and malignant progression, including migration, invasion, metastasis and survival (Choma et al., 2004; Manohar et al., 2004; Morini et al., 2000; Tsuji et al., 2002; Wang et al., 2004) . As MMP-9 has been implicated in some of these cell functions, our current data suggest that part of the role of α3β1 may be to regulate the stability and degradation of MMP-9 mRNA. The acquisition by immortalized cells of α3β1-dependent mRNA stability may extend to other mRNA transcripts as well and could represent an important selection step during tumor progression. Therefore, further study of the signal transduction pathways involved in this regulation may lead to the identification of therapeutic targets for inhibiting carcinoma progression and/or metastasis that are specific to cancer cells.
